Abstract
To describe a case of macular pucker treated by non-vitrectomizing vitreoretinal surgery using a 25-gauge high-flow infusion cannula with a 27-gauge illumination source (Photon™ II; both from Synergetics USA Inc., O’Fallon, MO). A 42-year-old man complaining of visual reduction and metamorphopsia was referred to the Vitreoretinal Surgery Unit, where he underwent full ophthalmic examination. Best corrected visual acuity (BCVA) at baseline was 0.5 in the left eye (LE) and 1.0 in the right eye. He was diagnosed with epiretinal membrane (ERM) in the LE. The surgical procedure envisaged two-port sclerotomy, one for the infusion line of the 27-gauge Photon™ II light source, the other for the 25-gauge trocar in the superotemporal quadrant. The ERM was removed with a 25-gauge disposable forceps. The infusion line was placed for safety in the event of additional intraocular pressure being needed, but was not required. The 27-gauge light source afforded good visualization of the posterior pole and the ERM. At 12 months, the patient’s BCVA had improved to 1.0, and his cataract has not progressed. A 25-gauge infusion line used with the photon illumination may further improve non-vitrectomizing surgery, minimizing risk and optimizing outcome. Further trials are required to validate these preliminary observations.
Similar content being viewed by others
References
de Bustros S, Thompson JT, Michels RG, Rice TA, Glaser BM (1988) Vitrectomy for idiopathic epiretinal membranes causing macular pucker. Br J Ophthalmol 72(9):692–695
Sawa M, Ohji M, Kusaka S, Sakaguchi H, Gomi F, Saito Y, Tano Y (2005) Nonvitrectomizing vitreous surgery for epiretinal membrane long-term follow-up. Ophthalmology 112(8):1402–1408
Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY (1993) The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111(6):831–836
Machemer R (1995) The development of pars plana vitrectomy: a personal account. Graefes Arch Clin Exp Ophthalmol 233(8):453–468
Michels RG (1981) Vitreous surgery for macular pucker. Am J Ophthalmol 92(5):628–639
Wang CC, Charles S (1984) Microsurgical instrumentation for vitrectomy: Part II. J Clin Eng 9(1):63–71
Rizzo S, Genovesi-Ebert F, Murri S et al (2006) 25-Gauge sutureless vitrectomy and standard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: a comparative pilot study. Graefes Arch Clin Exp Ophthalmol 244:472–479
Patelli F, Radice P, Zumbo G, Frisone G, Fasolino G (2007) 25-Gauge macular surgery: results and complications. Retina 27(6):750–754
Scartozzi R, Bessa AS, Gupta OP, Regillo CD (2007) Intraoperative sclerotomyrelated retinal breaks for macular surgery, 20- vs 25-gauge vitrectomy systems. Am J Ophthalmol 143:155–156
Okuda T, Nishimura A, Kobayashi A, Sugiyama K (2007) Postoperative retinal break after 25-gauge transconjunctival sutureless vitrectomy: report of four cases. Graefes Arch Clin Exp Ophthalmol 245:155–157
Lakhanpal RR, Humayun MS, de Juan E et al (2005) Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology 112:817–824
Fujii GY, De Juan E, Humayun MS et al (2002) Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology 109:1814–1820
Ibarra MS, Hermel M, Prenner JL, Hassan TS (2005) Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol 139:831–836
Shaikh S, Ho S, Richmond PP, Olson JC, Barnes CD (2007) Untoward outcomes in 25-gauge versus 20-gauge vitreoretinal surgery. Retina 27:1048–1053
Foos RY (1974) Vitreoretinal juncture-simple epiretinal membranes. Albrecht Von Graefes Arch Klin Exp Ophthalmol 189(4):231–250
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mariotti, C., Viti, F. & Neri, P. Non-vitrectomizing surgery for idiopathic macular pucker using a 25-gauge synergetics high-flow infusion with a 27-gauge light (Photon™ II, Synergetics USA, Inc.). Int Ophthalmol 30, 323–327 (2010). https://doi.org/10.1007/s10792-009-9322-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-009-9322-y